| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 46.7% | 7/15 |
| Female | 40% | 6/15 |
| Indifferent | 0% | 0/15 |
| Unknown | 13.3% | 2/15 |
| General | ||
| 6.7% | 1/15 | |
| 6.7% | 1/15 | |
| 13.3% | 2/15 | |
| 20% | 3/15 | |
| 13.3% | 2/15 | |
| 46.7% | 7/15 | |
| 33.3% | 5/15 | |
| 73.3% | 11/15 | |
| 33.3% | 5/15 | |
| 60% | 3/5 | |
| Neurology | ||
| 40% | 6/15 | |
| 66.7% | 10/15 | |
| 33.3% | 5/15 | |
| Facial abnormalities | ||
| 40% | 6/15 | |
| 26.7% | 4/15 | |
| 33.3% | 5/15 | |
| 53.3% | 8/15 | |
| Visual and hearing impairments | ||
| 6.7% | 1/15 | |
| 60% | 9/15 | |
| Heart | ||
| 20% | 3/15 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/15 |
| Gastrointestinal | ||
| 20% | 3/15 | |
| Urogenital | ||
| 6.7% | 1/15 | |
| Skeleton | ||
| 40% | 6/15 | |
| Skin / Hair / Nails | ||
| 26.7% | 4/15 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/15 |
| Metabolic | 0% | 0/15 |
| 20% | 3/15 | |
| Neoplasia | ||
| 6.7% | 1/15 | |
| Inheritance | ||
| 66.7% | 10/15 | |
LHX2